Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID, also known as ACPA, is a chemical compound that belongs to the class of amino acid derivatives. It is a potent and selective agonist for the cannabinoid receptor CB1, which makes it useful for research purposes in the field of neuroscience. ACPA possesses unique properties that allow it to interact with the endocannabinoid system, making it a promising candidate for various therapeutic applications.

682804-23-5

Post Buying Request

682804-23-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

682804-23-5 Usage

Uses

Used in Neuroscience Research:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a research tool for studying the endocannabinoid system and its role in various physiological processes. Its selectivity for the CB1 receptor makes it valuable in understanding the mechanisms of action and potential therapeutic targets related to this receptor.
Used in Pharmaceutical Development:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a potential therapeutic agent for the treatment of neurodegenerative diseases, chronic pain, and addiction. Its agonistic activity on the CB1 receptor suggests that it may have beneficial effects in managing these conditions by modulating the endocannabinoid system.
Used in Drug Discovery:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a lead compound in drug discovery efforts, as its unique properties and interactions with the CB1 receptor may provide insights into the development of novel therapeutic agents targeting the endocannabinoid system.
Used in Neurodegenerative Disease Treatment:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a potential treatment for neurodegenerative diseases, such as Alzheimer's and Parkinson's, due to its ability to modulate the endocannabinoid system and potentially slow down the progression of these diseases.
Used in Chronic Pain Management:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a potential therapeutic agent for managing chronic pain, as its agonistic activity on the CB1 receptor may help alleviate pain by modulating the endocannabinoid system's pain-relieving properties.
Used in Addiction Treatment:
3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID is used as a potential treatment for addiction, as its interaction with the CB1 receptor may help reduce cravings and withdrawal symptoms associated with substance abuse disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 682804-23-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,2,8,0 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 682804-23:
(8*6)+(7*8)+(6*2)+(5*8)+(4*0)+(3*4)+(2*2)+(1*3)=175
175 % 10 = 5
So 682804-23-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO2/c9-7(5-8(10)11)6-3-1-2-4-6/h6-7H,1-5,9H2,(H,10,11)

682804-23-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-3-cyclopentylpropanoic acid

1.2 Other means of identification

Product number -
Other names 3-amino-3-cyclopentylpropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:682804-23-5 SDS

682804-23-5Upstream product

682804-23-5Downstream Products

682804-23-5Relevant articles and documents

2-CYANOPYRROLES AND THEIR ANALOGUES AS DDP-IV INHIBITORS

-

Page/Page column 50, (2010/02/08)

The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV having the formula I: (I) The invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of such compounds for the manufacture of medicaments for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 682804-23-5